Public disclosure of inside information according to article 17 MAR
Leverkusen, Germany (pta034/02.08.2022/16:10) - The Management Board and the Supervisory Board of Biofrontera AG (hereinafter also referred to as the "Company") have proposed to the Annual General Meeting of Biofrontera AG convened for August 23, 2022 to reduce the seats of the Supervisory Board to five members and to change the Articles of Incorporation accordingly after one member who was elected on December 14, 2021 has prematurely resigned. The Supervisory Board has therefore not submitted a proposal for the election of a sixth member to the Annual General Meeting convened for August 23, 2022.
Maruho Deutschland GmbH and other shareholders today submitted the proposal to elect Prof. Dr. Hermann Lübbert, Leverkusen, Executive Chairman of Biofrontera Inc. as the sixth member of the Supervisory Board. Prof. Dr. Lübbert is the founder of Biofrontera AG and was the CEO of Biofrontera AG until December 13, 2021.
Previously, Deutsche Balaton AG, a company of the Deutsche Balaton Group, had added agenda item 8 (Election of a Supervisory Board member) to the agenda of the Annual General Meeting on August 23, 2022, and proposed Prof. Dr. Karin Lergenmüller, Professor of Marketing and General Business Administration at Rhein-Main University of Applied Sciences, Wiesbaden, for election as the sixth member.
The wording of the motions and proposed resolutions of the aforementioned shareholders is available at https://www.biofrontera.com/en/investors/annual-general-meeting.
(end)
emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com
ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: US OTC